Common Contracts
5 similar Executive Employment Agreement contracts by Lipocine Inc.
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT for Morgan BrownExecutive Employment Agreement • March 6th, 2017 • Lipocine Inc. • Pharmaceutical preparations • Utah
This Second Amended and Restated Executive Employment Agreement (the “Agreement”), is dated March 3, 2017 and amends and restates the Amended and Restated Executive Employment Agreement made between Lipocine Inc. (the “Company”) and Morgan Brown (“Executive”) (collectively, the “Parties”), dated effective as of January 7, 2014.
EXECUTIVE EMPLOYMENT AGREEMENT for Mahesh V. PatelExecutive Employment Agreement • January 7th, 2014 • Lipocine Inc. • Pharmaceutical preparations • Utah
This Executive Employment Agreement (the “Agreement”), made between Lipocine Inc. (the “Company”) and Mahesh V. Patel, Ph.D. (“Executive”) (collectively, the “Parties”), is effective as of January 7, 2014.
EXECUTIVE EMPLOYMENT AGREEMENT for Gerald SimmonsExecutive Employment Agreement • January 7th, 2014 • Lipocine Inc. • Pharmaceutical preparations • Utah
This Executive Employment Agreement (the “Agreement”), made between Lipocine Inc. (the “Company”) and Gerald Simmons (“Executive”) (collectively, the “Parties”), is effective as of January 7, 2014.
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT for Morgan BrownExecutive Employment Agreement • January 7th, 2014 • Lipocine Inc. • Pharmaceutical preparations • Utah
This Amended and Restated Executive Employment Agreement (the “Agreement”), is dated January 7, 2014 and amends and restates the Executive Employment Agreement made between Lipocine Inc. (the “Company”) and Morgan Brown (“Executive”) (collectively, the “Parties”), dated effective as of September 15, 2013.
EXECUTIVE EMPLOYMENT AGREEMENT for Dr. Srinivasan VenkateshwaranExecutive Employment Agreement • January 7th, 2014 • Lipocine Inc. • Pharmaceutical preparations • Utah
This Executive Employment Agreement (the “Agreement”), made between Lipocine Inc. (the “Company”) and Dr. Srinivasan Venkateshwaran (“Executive”) (collectively, the “Parties”), is effective as of January 7, 2014.
